Cellectar Biosciences, Inc. Gains 36.26%

Tue, Sep 05, 2023 at 07:10 PM
Cellectar Biosciences, Inc. Gains 36.26%

Cellectar Biosciences, Inc. (CLRB:NASDAQ) jumped higher at $2.48, a gain of 36.3%. On Tue, Sep 05, 2023, CLRB:NASDAQ touched a New 2-Week High of $2.48. The stock got featured on our News Catalysts scanner on Tue, Sep 05, 2023 at 08:54 AM in the 'PRIVATE PLACEMENT' category. From Tue, Aug 22, 2023, the stock recorded 55.56% Up Days and 30.00% Green Days

About Cellectar Biosciences, Inc. (CLRB:NASDAQ)

Cellectar Biosciences Inc is a biopharmaceutical company. It is engaged in developing compounds for treatment and imaging of cancer. Its portfolio consists of PET imaging agents, optical imaging agents, and therapeutic agents.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.